Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR was delisted on the 16th of April, 2019.
2 hedge funds and large institutions have $567K invested in Osiris Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
33% more capital invested
Capital invested by funds: $425K → $567K (+$142K)
0% more funds holding
Funds holding: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
+$12.8K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FIM
1
Freedom Investment Management
Hartford,
Connecticut
| $495K | +$12.8K | +2,131 | +3% |
|
2
Public Employees Retirement Association of Colorado
Denver,
Colorado
| $72K | – | – | – |
|
OSIR Hedge Fund Activity: Q4 2017 in Review
2 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q4 2017, worth a combined $567K — up 33% from $425K a quarter earlier.
Fund positioning in OSIR was balanced in Q4 2017: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Freedom Investment Management, adding an estimated $12.8K.
- 2 institutional investors held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q4 2017, unchanged from Q3 2017.
- Funds reported $567K of Osiris Therapeutics, Inc. Common Stock stock for Q4 2017, up 33% quarter-over-quarter.
- 0 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q4 2017 and 0 closed out.
- The largest Osiris Therapeutics, Inc. Common Stock buyer in Q4 2017 was Freedom Investment Management, an estimated $12.8K added.
Based on aggregated 13F filings for Q4 2017.